1. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial 
Dr Jort Kropff, MD, Simone Del Favero, PhD, Jerome Place, MSc, Chiara Toffanin, PhD, Roberto Visentin, MSc, Marco Monaro, MSc, Mirko Messori, MSc, Federico Di Palma, PhD, Giordano Lanzola, PhD, Anne Farret, MD, Federico Boscari, MD, Silvia Galasso, MD, Prof Paolo Magni, PhD, Prof Angelo Avogaro, MD, Patrick Keith-Hynes, PhD, Prof Boris P Kovatchev, PhD, Daniela Bruttomesso, MD, Prof Claudio Cobelli, PhD, J Hans DeVries, MD, Prof Eric Renard, MD, Prof Lalo Magni, PhD 
The Lancet Diabetes & Endocrinology 
Volume 3, Issue 12, Pages (December 2015)
DOI: /S (15)
Copyright © 2015 Elsevier Ltd Terms and Conditions

2. Figure 1 Trial profile AP=artificial pancreas.
The Lancet Diabetes & Endocrinology 2015 3, DOI: ( /S (15) )
Copyright © 2015 Elsevier Ltd Terms and Conditions

3. Figure 2
Percentage of time spent in and below target glucose concentration range for all study participants during 2000–0800 h
Mean evening and night (2000–0800 h) percentage time in target range (3·9–10·0 mmol/L) is given for each patient for the control period, which is connected to the mean percentage time in target range for the AP period. The diameter of the circle shows percentage of time (either <1% or 5%) spent below the target range in either period. AP=artificial pancreas.
The Lancet Diabetes & Endocrinology 2015 3, DOI: ( /S (15) )
Copyright © 2015 Elsevier Ltd Terms and Conditions

4. Figure 3 24 h glucose control profile
The glucose control profile of all patients analysed is shown as superimposed continuous traces of glucose monitoring during the AP and control periods. Mean blood glucose is given with 1 SD. Purple shading represents the SD for the AP period and blue shading represents the SD for the control period. 3·9–10 mmol/L represents the target glucose concentration range and 4·4–7·8 mmol/L represents the tight glucose target. AP=artificial pancreas.
The Lancet Diabetes & Endocrinology 2015 3, DOI: ( /S (15) )
Copyright © 2015 Elsevier Ltd Terms and Conditions